Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AlphaTON Capital ( (ATON) ) just unveiled an announcement.
On September 3, 2025, AlphaTON Capital Corp announced a significant financing transaction to launch a TON digital asset treasury strategy, appointing DWF MaaS Limited to manage $20 million initially, with plans to increase this to $75 million over three months. The company expects gross proceeds of approximately $36.2 million from this transaction, which is anticipated to close during the week of September 22, 2025. Additionally, AlphaTON entered into a master loan agreement with BitGo Prime, LLC, allowing for a drawdown of up to $35 million at a 14.75% interest rate, secured by TON collateral.
Spark’s Take on ATON Stock
According to Spark, TipRanks’ AI Analyst, ATON is a Neutral.
Portage Biotech Inc. exhibits significant financial weaknesses, such as no revenue and persistent losses, which heavily weigh down the overall score. Despite strong technical indicators suggesting bullish momentum, the poor valuation metrics and financial performance hinder the stock’s attractiveness. The absence of earnings call data or notable corporate events leaves these factors out of consideration.
To see Spark’s full report on ATON stock, click here.
More about AlphaTON Capital
AlphaTON Capital Corp, formerly known as Portage Biotech Inc., is a company based in the British Virgin Islands. It is involved in the management and trading of digital assets, with a focus on implementing a TON digital asset treasury strategy for the Telegram ecosystem.
Average Trading Volume: 123,358
Technical Sentiment Signal: Sell
Current Market Cap: $14.36M
For detailed information about ATON stock, go to TipRanks’ Stock Analysis page.